Trigot en es it fr

Trigot Brand names, Trigot Analogs

Trigot Brand Names Mixture

  • No information avaliable

Trigot Chemical_Formula


Trigot RX_link

No information avaliable

Trigot fda sheet

Trigot msds (material safety sheet)

Trigot Synthesis Reference

No information avaliable

Trigot Molecular Weight

591.741 g/mol

Trigot Melting Point

No information avaliable

Trigot H2O Solubility

No information avaliable

Trigot State


Trigot LogP


Trigot Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Trigot Indication

For use as an adjunct therapy for patients with dementia

Trigot Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Trigot Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Trigot side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Trigot Patient Information

No information avaliable

Trigot Organisms Affected

Humans and other mammals